StonvexLoading…
StonvexStonvexStonvexCore line items from FNLC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $39.14M | $160.27M | $41.01M | $39.83M |
Operating Income | $10.90M | $41.94M | $11.08M | $9.85M |
Net Income | $8.99M | $34.39M | $9.08M | $8.06M |
EPS (Diluted) | $0.80 | $3.07 | $0.81 | $0.72 |
Total Assets | $3.20B | $3.17B | $3.20B | $3.20B |
Total Liabilities | $2.91B | $2.88B | $2.92B | $2.93B |
Cash & Equivalents | $23.61M | $27.78M | $31.61M | $27.36M |
Free Cash Flow OCF − CapEx | $22.25M | $34.59M | $20.66M | $8.06M |
Shares Outstanding | 11.27M | 11.22M | 11.21M | 11.21M |